Cite
[Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura].
MLA
Wang, Lin, et al. “[Combination Therapy of Thymosin Alpha1 and High Dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura].” Zhonghua Nei Ke Za Zhi, vol. 46, no. 4, Apr. 2007, pp. 274–76. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17637261&authtype=sso&custid=ns315887.
APA
Wang, L., Guo, C., Hou, M., Li, L., Zhang, C., Chen, F., Qin, P., Peng, J., He, W., & Chu, X. (2007). [Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura]. Zhonghua Nei Ke Za Zhi, 46(4), 274–276.
Chicago
Wang, Lin, Cheng-shan Guo, Ming Hou, Li-zhen Li, Chun-qing Zhang, Feng Chen, Ping Qin, Jun Peng, Wei-dong He, and Xiao-xia Chu. 2007. “[Combination Therapy of Thymosin Alpha1 and High Dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura].” Zhonghua Nei Ke Za Zhi 46 (4): 274–76. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17637261&authtype=sso&custid=ns315887.